Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
DXC Technology $230 million revolving facility increase
We advised the borrower on the financing
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Semtech $250 million convertible senior notes offering
We advised Semtech on its private placement of 4% convertible senior notes due 2028
MSCI acquisition of Trove Research
We are advising MSCI on the acquisition
ExxonMobil $59.5 billion acquisition of Pioneer Natural Resources
We are advising ExxonMobil on the transaction
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
NICE acquisition of LiveVox
We are advising NICE on the acquisition
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions